China: Sustaining Recovery and Pursuing High-Quality Growth

China has strong economic foundations to pursue and achieve high-quality growth. The country’s recovery from the 2020 downturn has stayed intact despite the slowdown in H2 2021 and H1 2022 due to COVID-19 outbreaks, headwinds in the property sector, and supply side disruptions. Against the backdrop of a resilient labor market, well-contained inflation pressures, strong external position and sound banking system, China’s economic recovery should regain momentum in H2 2022, with growth for the year coming in at about 4.8 percent.

Continue ReadingChina: Sustaining Recovery and Pursuing High-Quality Growth

ASEAN+3 Poised for Robust Growth Despite Threats from Ukraine War and Tighter Financial Conditions

The ASEAN+3 Macroeconomic Research Office (AMRO) today shaved down its short-term growth forecast for the ASEAN+3 region, reflecting the impact of the recent COVID-19 outbreak in China and stronger headwinds arising from the war in Ukraine and tighter global financial conditions.

Continue ReadingASEAN+3 Poised for Robust Growth Despite Threats from Ukraine War and Tighter Financial Conditions

Quarterly Update of the ASEAN+3 Regional Economic Outlook (AREO) – July 2022

In this July 2022 quarterly update, AMRO shaves down its short-term growth forecast for the ASEAN+3 region to reflect the impact of the recent COVID-19 outbreak in China and stronger headwinds arising from the war in Ukraine and tighter global financial conditions.

Continue ReadingQuarterly Update of the ASEAN+3 Regional Economic Outlook (AREO) – July 2022

Watch ASEAN+3 Regional Economic Outlook 2022: Risks abound but growth to normalize as COVID-19 recedes

AMRO forecasts the ASEAN+3 region to grow by 4.7% in 2022 and 4.6% in 2023. While growth is expected to normalize as the pandemic recedes, the outlook is clouded by new and legacy risks. Watch the highlights of the 2022 ASEAN+3 Regional Economic Outlook.

Continue ReadingWatch ASEAN+3 Regional Economic Outlook 2022: Risks abound but growth to normalize as COVID-19 recedes